Evidence map›Paper›PMID 34008862›Full record

ArticleThe EMBO journal2021

Loss of all three APP family members during development impairs synaptic function and plasticity, disrupts learning, and causes an autism-like phenotype.

Vicky Steubler, Susanne Erdinger, Michaela K Back, Susann Ludewig, Dominique Fässler, Max Richter, Kang Han, Lutz Slomianka, Irmgard Amrein, Jakob von Engelhardt and 3 more

Abstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. The ASD Risk GenebioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The Amyloid Precursor Protein Regulates Synaptic Transmission at Medial Perforant Path Synapses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Vicky SteublerDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Susanne ErdingerDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Michaela K BackInstitute of Pathophysiology, Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Susann LudewigDivision of Cellular Neurobiology, Zoological Institute, TU Braunschweig, Braunschweig, Germany.
Dominique FässlerDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Max RichterDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Kang HanDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Lutz SlomiankaInstitute of Anatomy and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-5402-0934
Irmgard AmreinInstitute of Anatomy and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Jakob von EngelhardtInstitute of Pathophysiology, Focus Program Translational Neuroscience (FTN), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0003-3861-3294
David P WolferInstitute of Anatomy and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-5957-1401
Martin KorteDivision of Cellular Neurobiology, Zoological Institute, TU Braunschweig, Braunschweig, Germany.ORCID 0000-0001-6956-5913
Ulrike C MüllerDepartment of Functional Genomics, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-0587-2575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The key role of APP for Alzheimer pathogenesis is well established. However, perinatal lethality of germline knockout mice lacking the entire APP family has so far precluded the analysis of its physiological functions for the developing and adult brain. Here, we generated conditional APP/APLP1/APLP2 triple KO (cTKO) mice lacking the APP family in excitatory forebrain neurons from embryonic day 11.5 onwards. NexCre cTKO mice showed altered brain morphology with agenesis of the corpus callosum and disrupted hippocampal lamination. Further, NexCre cTKOs revealed reduced basal synaptic transmission and drastically reduced long-term potentiation that was associated with reduced dendritic length and reduced spine density of pyramidal cells. With regard to behavior, lack of the APP family leads not only to severe impairments in a panel of tests for learning and memory, but also to an autism-like phenotype including repetitive rearing and climbing, impaired social communication, and deficits in social interaction. Together, our study identifies essential functions of the APP family during development, for normal hippocampal function and circuits important for learning and social behavior.

Indexed as

Amyloid beta-Protein PrecursorAnimalsAutistic DisorderBehavior, AnimalCA1 Region, HippocampalFemaleLearningLong-Term PotentiationMaleMiceMice, KnockoutNeuronsPhenotypeProsencephalonSocial BehaviorSynapsesAmyloid beta-Protein PrecursorAplp1 protein, mouseAplp2 protein, mouseAPP protein, mouseAlzheimerAmyloid precursor proteinAutism spectrum disorderlearning and memorysynaptic plasticity

Identifiers

PMID34008862
PMCPMC8204861

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.